ARCHIVES

Isis 3521 Gets Fast-track Status For FDA Review.

This article is from The Cancer Letter archive.

Vol. 26 No. 44 | December 1, 2000

Download PDF Visit The Full Archive

Related Articles

Cancer Policy: NCAB Recommends Mammograms Every 1 to 2 Years for Average Risk Women 40-49

April 4, 1997

NCAB Okays Concepts For ICI Contract Support, Databases

October 11, 1991

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

NIH Programs: Advisory Panel Formed On Cancer and Alternative Medicine

July 16, 1999

Should Be Cut First, DCT Board Says

December 4, 1981

In Brief: Wells, Gardner, Brennan Lead Surgical Oncology; Young, Flynn, Are New officers For Head & Neck

March 26, 1993